NO891921L - Ekspresjon av s- og pres2- proteiner av hepatitt b i metylotrof gjaer. - Google Patents

Ekspresjon av s- og pres2- proteiner av hepatitt b i metylotrof gjaer.

Info

Publication number
NO891921L
NO891921L NO89891921A NO891921A NO891921L NO 891921 L NO891921 L NO 891921L NO 89891921 A NO89891921 A NO 89891921A NO 891921 A NO891921 A NO 891921A NO 891921 L NO891921 L NO 891921L
Authority
NO
Norway
Prior art keywords
metylotrophy
hepatite
expression
pres2
proteins
Prior art date
Application number
NO89891921A
Other languages
English (en)
Other versions
NO891921D0 (no
NO300465B1 (no
Inventor
Gregory Patrick Thill
Original Assignee
Phillips Petroleum Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phillips Petroleum Co filed Critical Phillips Petroleum Co
Publication of NO891921D0 publication Critical patent/NO891921D0/no
Publication of NO891921L publication Critical patent/NO891921L/no
Publication of NO300465B1 publication Critical patent/NO300465B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO891921A 1988-05-13 1989-05-11 Fremgangsmåte til fremstilling av terapeutisk aktive antigene HBV-partikler som består av S- og preS2-proteiner NO300465B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19371488A 1988-05-13 1988-05-13

Publications (3)

Publication Number Publication Date
NO891921D0 NO891921D0 (no) 1989-05-11
NO891921L true NO891921L (no) 1989-11-14
NO300465B1 NO300465B1 (no) 1997-06-02

Family

ID=22714736

Family Applications (1)

Application Number Title Priority Date Filing Date
NO891921A NO300465B1 (no) 1988-05-13 1989-05-11 Fremgangsmåte til fremstilling av terapeutisk aktive antigene HBV-partikler som består av S- og preS2-proteiner

Country Status (25)

Country Link
US (2) US5670630A (no)
EP (1) EP0341746B1 (no)
JP (1) JP2614314B2 (no)
KR (1) KR100193701B1 (no)
CN (1) CN1038668A (no)
AT (1) ATE151109T1 (no)
AU (1) AU618596B2 (no)
CA (1) CA1340617C (no)
DD (1) DD285373A5 (no)
DE (1) DE68927921T2 (no)
DK (1) DK235289A (no)
ES (1) ES2101676T3 (no)
FI (2) FI104639B (no)
GR (1) GR3023985T3 (no)
HU (1) HU207532B (no)
IE (1) IE81158B1 (no)
IL (1) IL90161A0 (no)
IN (1) IN171696B (no)
MX (1) MX26715A (no)
NO (1) NO300465B1 (no)
NZ (1) NZ228948A (no)
PL (1) PL161997B1 (no)
PT (1) PT90553A (no)
YU (1) YU98689A (no)
ZA (1) ZA893440B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032516A (en) * 1985-10-25 1991-07-16 Phillips Petroleum Company Pichia pastoris alcohol oxidase II regulatory region
PL168408B1 (pl) * 1989-08-03 1996-02-29 Smithkline Beecham Biolog Sposób wytwarzania stransformowanego mikroorganizmu PL
GB9007416D0 (en) * 1990-04-02 1990-05-30 Wellcome Found Expression of heterologous protein in yeast
US6197548B1 (en) 1990-04-02 2001-03-06 Medeva Pharma Limited Transformed Pichia expressing the pertactin antigen
EP0521348A1 (en) * 1991-06-18 1993-01-07 Korea Institute Of Science And Technology Chimeric antibody with specificity for hepatitis B virus pre-S2 surface antigen and cell line producing same
LT3988B (en) 1992-02-17 1996-06-25 Fermentas Biotech Inst Recombinant plasmides pfs19, pfps2-48 and pjlfds1 codingsynthesis of human hepatite b of surfice virus antigenes, methods fof producing thereof
CA2101610A1 (en) * 1992-08-07 1994-02-08 William D. Prevatt Production of bacillus entomotoxins in methylotrophic yeast
GB9402832D0 (en) * 1994-02-15 1994-04-06 Smith Kline Beecham Biolog S A Novel process
US5716808A (en) * 1995-11-09 1998-02-10 Zymogenetics, Inc. Genetic engineering of pichia methanolica
US5955349A (en) * 1996-08-26 1999-09-21 Zymogenetics, Inc. Compositions and methods for producing heterologous polypeptides in Pichia methanolica
JP2000500014A (ja) * 1995-11-09 2000-01-11 ザイモジェネティクス，インコーポレイティド ピヒア・メタノリカ中で異種ポリペプチドを生産するための組成物と方法
MX9605082A (es) 1996-10-24 1998-04-30 Univ Autonoma De Nuevo Leon Levaduras metilotroficas modificadas geneticamente para la produccion y secrecion de hormona de crecimiento humano.
EP1773303A2 (en) * 2004-05-25 2007-04-18 Chimeracore, Inc. Self-assembling nanoparticle drug delivery system
CN1704475A (zh) * 2004-05-31 2005-12-07 成都生物制品研究所 羧端含前s2免疫决定簇的乙肝表面抗原融合基因及蛋白质
CA2589591A1 (en) * 2004-07-22 2006-03-09 Glycofi, Inc. Malate synthase regulatory sequences for heterologous gene expression in pichia
CN100381171C (zh) * 2004-12-30 2008-04-16 成都生物制品研究所 含前s1、前s2和s抗原决定簇的乙肝表面抗原复合颗粒
JP2009533350A (ja) * 2006-04-07 2009-09-17 キメロス， インコーポレイテッド Ｂ細胞悪性疾患を処置するための組成物および方法
EP2134740A2 (en) * 2007-04-09 2009-12-23 Chimeros, Inc. Self-assembling nanoparticle drug delivery system
WO2010120874A2 (en) 2009-04-14 2010-10-21 Chimeros, Inc. Chimeric therapeutics, compositions, and methods for using same
EP2747774A4 (en) 2011-09-09 2015-02-11 Biomed Realty L P METHOD AND COMPOSITIONS FOR CONTROLLING VIRUS PROTECTION
CN116064533A (zh) 2012-10-23 2023-05-05 基因工具股份有限公司 用于切割靶dna的组合物及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR76274B (no) * 1981-08-04 1984-08-04 Univ California
EP0401941A3 (en) * 1984-07-11 1991-04-17 Takeda Chemical Industries, Ltd. Hepatitis b virus surface antigen and production thereof
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
US4816564A (en) * 1986-01-31 1989-03-28 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
JPS62236496A (ja) * 1986-04-07 1987-10-16 Green Cross Corp:The ＨＢｓＡｇの製造方法
US4963483A (en) * 1987-10-13 1990-10-16 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
IL89991A0 (en) * 1988-04-25 1989-12-15 Phillips Petroleum Co Expression of hepatitis b pres2 protein in methylotrophic yeasts

Also Published As

Publication number Publication date
NO891921D0 (no) 1989-05-11
FI892312A0 (fi) 1989-05-12
ZA893440B (en) 1990-01-31
JP2614314B2 (ja) 1997-05-28
DE68927921T2 (de) 1997-07-17
AU3473489A (en) 1989-11-16
DK235289D0 (da) 1989-05-12
US5650296A (en) 1997-07-22
HUT52557A (en) 1990-07-28
FI104639B (fi) 2000-03-15
NO300465B1 (no) 1997-06-02
PL279426A1 (en) 1990-01-22
IL90161A0 (en) 1989-12-15
YU98689A (sh) 1992-07-20
MX26715A (es) 1993-10-01
KR100193701B1 (ko) 1999-06-15
JPH0227990A (ja) 1990-01-30
IE81158B1 (en) 2000-05-03
DK235289A (da) 1989-11-14
US5670630A (en) 1997-09-23
EP0341746B1 (en) 1997-04-02
DD285373A5 (de) 1990-12-12
FI19992546A (fi) 1999-11-29
IN171696B (no) 1992-12-12
HU207532B (en) 1993-04-28
EP0341746A2 (en) 1989-11-15
AU618596B2 (en) 1992-01-02
NZ228948A (en) 1991-06-25
CN1038668A (zh) 1990-01-10
CA1340617C (en) 1999-06-29
FI892312A (fi) 1989-11-14
FI107265B (fi) 2001-06-29
GR3023985T3 (en) 1997-10-31
ATE151109T1 (de) 1997-04-15
IE891563L (en) 1989-11-13
KR890017361A (ko) 1989-12-15
EP0341746A3 (en) 1991-04-24
DE68927921D1 (de) 1997-05-07
PL161997B1 (pl) 1993-08-31
ES2101676T3 (es) 1997-07-16
PT90553A (pt) 1989-11-30

Similar Documents

Publication Publication Date Title
NO891921D0 (no) Ekspresjon av s- og pres2- proteiner av hepatitt b i metylotrof gjaer.
DE68929115T2 (de) Verfahren zur Herstellung von menschlichem Serumalbumin in Hefe
DE68928380D1 (de) Expression von menschlichen Serumalbumin in methylotrophischen Hefen
PH25120A (en) Replicable expression vehicle and process of preparation thereof
AU3597089A (en) Method for producing nonhyperglycosylated hepatitis b virus proteins
DE68923496D1 (de) Verfahren zur Herstellung von motilinähnlichen Polypeptiden und seine Expression.
DE59310073D1 (de) Verfahren zur Inaktivierung von Viren in Präparationen von Proteinen
JPS645492A (en) Production of b type hepatitis virus protein in yeast
IE891315L (en) Expression of hepatitis b. pres2 protein in methylotrophic¹yeasts
EP0503252A3 (en) Recombinant proteins having the immunoreactivity of hepatitis b virus e antigens (hbeag), method for their production and their application in immunoassays and as vaccines

Legal Events

Date Code Title Description
MK1K Patent expired